Lab & Diagnostic Provider Industry News

Best Practices in Revenue Cycle Management

For Laboratories

A Final Verdict in ACLA vs Azar?

For Laboratories

UHC Genetic and Molecular Lab Testing Updates effective June 1, 2021

For Laboratories

Laboratory News Brief – March 2021

For Laboratories

How To Address Top Revenue Cycle Challenges Facing Labs

For Laboratories

UnitedHealthcare Designated Diagnostic Provider Program (DDP) set for July 1 Launch

For Laboratories

Biodesix

For Laboratories

Potential New CMS COVID-19 Testing Policies & Pricing on the Horizon?

For Laboratories

Examine COVID Claims to Find RCM Weaknesses in Your Lab

For Laboratories

Laboratory News Brief – December 2020

For Hospitals & Physician Groups

New CMS Rule Attempts to Alleviate the Prior Authorization Burden

For Hospitals & Physician Groups

New COVID-19 Testing Price Transparency Requirements Effective Immediately

For Laboratories

Laboratory News Brief – November 2020

For Hospitals & Physician Groups

Government Takes Action to Ensure Coverage of COVID-19 Vaccine

For Laboratories

COVID-19 Testing Payments and Regulations: What Labs Need to Know

For Laboratories

How to Bill for Medicare Add-On Payment for COVID-19 Diagnostic Tests

For Laboratories

Larger Payments for Labs Producing Faster COVID-19 Results

For Laboratories

COVID-19 Test Pricing: Know the Facts, Protect Your Lab’s Reputation

For Hospitals & Physician Groups

Women Among the Hardest Hit Financially by COVID-19 Pandemic

For Laboratories

UnitedHealthcare Delays Deadline for Lab Test Registry to January 1

For Laboratories

Laboratory News Brief – August 2020

For Laboratories

Navigating Reimbursement for Liquid Biopsy Cancer Testing

For Laboratories

COVID-19: Insurers Exempt from Covering Workplace Testing

For Laboratories

Laboratory News Brief – June 2020

For Laboratories

Laboratory News Brief – May 2020

For Laboratories

Laboratory News Brief – April 2020

For Laboratories

Laboratory News Brief – March 2020

For Laboratories

A New Era of Consumerism Facing Labs Today – How Do You Stay Competitive?

For Laboratories

Are You Collecting What You Are Owed? Five Tips to Help Plug Revenue Leaks

For Laboratories

Surprise Billing Legislation: An Update and Ways to Mitigate Your Risk

Compliance, Privacy & Security

MIPS Scoring for Facility-based Pathologists: 3 Things You Need to Know

For Laboratories

Seven Keys to Success to Improve Out-of-Network Collections

For Laboratories

Is Your Lab Applicable Under the New PAMA Definition?

For Laboratories

Patient Bad Debt Impacting Your Bottom Line?

For Laboratories

Patient Access Antidote: Retaining More Revenue with Front End Solutions

For Laboratories

Patient Access Antidote: How Labs Can Retain More Revenue

For Laboratories

Quadax Industry News Bulletin

For Laboratories

Pursue LDT Revenue Cycle Success with Cross-functional Collaboration

For Laboratories

Quadax Presents Strategic Considerations for Managing the Increasing Patient Cost-Share Trend

Compliance, Privacy & Security

FASB ASC 606: Prepare Your Laboratory for a Successful Transition

For Laboratories

Cross-functional Collaboration is Key to Diagnostic Test Commercialization

For Laboratories

ASC 606: Lessons Learned and What You Need to Know

For Laboratories

Mitigate Prior Authorization Challenges: A Guide to Best Practices

For Laboratories

14 Day Rule Regarding ADLT and MolPath Tests Continues to Show Movement

For Laboratories

Quadax Introduces Prior Authorization Management Service to Streamline the Authorization Process for Labs

For Laboratories

Prior Authorization – The Lab’s Dilemma

For Laboratories

Accelerate Receivables: Monitor KPIs for A/R Search and Rescue

For Laboratories

Patient Access Management – A Smart Start for Labs

For Laboratories

Gaining Coverage for Your Lab’s New Diagnostic Test

For Laboratories

Quadax Presenting at Diagnostic Coverage & Reimbursement Conference

For Laboratories

OPPS 2018 Revisions: Outpatient 14-Day Rule Changes to Laboratory DOS Policy

For Laboratories

Living with PAMA–What is Your Lab’s Prognosis?

For Laboratories

Defining Your Hospital Lab Program’s Value in the Face of PAMA Cuts

For Laboratories

Quadax Discusses Early Results of Prior Authorization at Molecular Med Tri-Con

For Laboratories

Quadax to Present at Diagnostic Coverage & Reimbursement Conference

For Laboratories

Is Your Lab Aware of CMS Claim Requirements for “Unlisted” Test Codes?

For Laboratories

Strategies for Managing Genetic and Molecular Test Preauthorization

For Hospitals & Physician Groups

Start Smart! Split Remits to Match and Relieve A/R

For Hospitals & Physician Groups

Fielding an All Star Healthcare Revenue Cycle Operations Team

Compliance, Privacy & Security

RAC Audits and What They Mean for Providers

Compliance, Privacy & Security

FASB New Standard on Revenue Recognition – Are You Ready for ASC 606?

For Laboratories

Leading Industry Innovation in the Healthcare Heartland

For Laboratories

Implications of Narrow Healthcare Networks on Laboratory Providers

For Hospitals & Physician Groups

How to Improve Payments as HDHPs Increase Patient Responsibility

For Laboratories

4 Strategies for Molecular Diagnostic Labs to Maximize Reimbursement

For Hospitals & Physician Groups

Go Green and $AVE! Convert Paper Remittance to Electronic Transactions

For Laboratories

Quadax Is Ready for PAMA Reporting